Chantel N. Trost

ORCID: 0000-0002-6782-2143
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • CRISPR and Genetic Engineering
  • Advanced biosensing and bioanalysis techniques
  • RNA and protein synthesis mechanisms
  • Insect symbiosis and bacterial influences
  • Viral Infections and Vectors
  • Vector-borne infectious diseases
  • Rabies epidemiology and control
  • Electrocatalysts for Energy Conversion
  • Mosquito-borne diseases and control
  • Plant Virus Research Studies

University of Toronto
2019-2024

Hospital for Sick Children
2024

National Institute of Technology Hamirpur
2020

University of Saskatchewan
2018-2020

CRISPR-Cas9 systems provide powerful tools for genome editing. However, optimal employment of this technology will require control Cas9 activity so that the timing, tissue specificity, and accuracy editing may be precisely modulated. Anti-CRISPR proteins, which are small, naturally occurring inhibitors CRISPR-Cas systems, well suited purpose. A number anti-CRISPR proteins have been shown to potently inhibit subgroups but their maximal inhibitory is generally restricted specific homologs....

10.1016/j.celrep.2019.10.017 article EN cc-by-nc-nd Cell Reports 2019-11-01

Abstract Phages and other mobile genetic elements express anti-CRISPR proteins (Acrs) to protect their genomes from destruction by CRISPR–Cas systems. Acrs usually block the ability of systems bind or cleave nucleic acid substrates. Here, we investigate an unusual Acr, AcrIF9, that induces a gain-of-function type I-F (Csy) complex, causing it strongly DNA lacks both PAM sequence complementarity. We show specific non-specific dsDNA compete for same site on Csy:AcrIF9 complex with rapid...

10.1093/nar/gkab092 article EN cc-by-nc Nucleic Acids Research 2021-02-04

Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) and CRISPR-associated (Cas) proteins serve as a formidable defense mechanism for bacteria against foreign DNA; on the other hand, some bacteriophages (phages) mobile genetic elements have evolved anti-CRISPR (Acr) to counteract CRISPR-Cas systems ensure their own survival. Because Acr provide phages with fitness advantage relative that they infect, accurately identifying inhibit has potential significantly positively impact...

10.1145/3584371.3613007 article EN cc-by 2023-09-03

Total genomic (g)DNA from 100 American dog ticks (Dermacentor variabilis) collected humans, dogs, raccoons, and skunks near Minnedosa (Manitoba, Canada) in 2005 was tested for the presence of Moellerella wisconsensis (Gammaproteobacteria: Enterobacteriales) using PCR. Although two gDNA samples derived attached to striped (Mephitis mephitis) contained M. DNA, it is unlikely that D. variabilis a vector this bacterium. Genomic DNA prepared washes external surfaces these (i.e., before extraction...

10.7589/2019-09-224 article EN Journal of Wildlife Diseases 2020-05-13

CRISPR-Cas9 systems provide powerful tools for genome editing. However, optimal employment of this technology will require control Cas9 activity so that the timing, tissue specificity, and accuracy editing may be precisely modulated. Anti-CRISPR proteins, which are small naturally-occurring inhibitors CRISPR-Cas systems, well-suited purpose. A number anti-CRISPR proteins have been shown to potently inhibit subgroups but their maximal inhibitory is generally restricted specific homologs....

10.2139/ssrn.3385124 article EN SSRN Electronic Journal 2019-01-01

ABSTRACT Phages and other mobile genetic elements express anti-CRISPR proteins (Acrs) to protect their genomes from destruction by CRISPR-Cas systems. Acrs usually block the ability of systems bind or cleave nucleic acid substrates. Here, we investigate an unusual Acr, AcrIF9, that induces a gain-of-function type I-F (Csy) complex, causing it strongly DNA lacks both PAM sequence complementarity. We show specific non-specific dsDNA compete for same site on Csy:AcrIF9 complex with rapid...

10.1101/2020.05.28.119941 preprint EN bioRxiv (Cold Spring Harbor Laboratory) 2020-05-29
Coming Soon ...